Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients

Abstract

The present study developed and validated a nine-lncRNA prognostic signature for individual mortality risk assessment in colorectal cancer patients. This nine-lncRNA prognostic signature is helpful to evaluate the individual mortality risk and to improve the decision making of individualized treatments in colorectal cancer patients.